Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison J Hahr

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
American Journal of Therapeutics|January 8, 2009
Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient settingAllison J Hahr, Mark E Molitch
Cardiology Clinics|July 13, 2010
Diabetes, cardiovascular risk and nephropathyAllison J Hahr, Mark E Molitch
Clinical Diabetes and Endocrinology|July 14, 2017
Management of diabetes mellitus in patients with chronic kidney diseaseAllison J Hahr, Mark E Molitch
Disease-A-Month : DM|March 2, 2010
Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient settingAllison J Hahr, Mark E Molitch
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 3, 2021
Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022Allison J Hahr, Mark E Molitch
BMC Research Notes|November 1, 2012
Primary hyperaldosteronism: challenges in subtype classificationBrian T Layden, Allison J Hahr, Dina M Elaraj
Disease-A-Month : DM|March 2, 2010
Topics in clinical pharmacology: cardiovascular and diabetes mellitusJohn Somberg, Antonio Cherubini, David T Lowenthal, et al.
Journal of Medical Internet Research|October 23, 2019
Electronic Health Record-Based Strategy to Promote Medication Adherence Among Patients With Diabetes: Longitudinal Observational StudyStacy Cooper Bailey, Amisha Wallia, Sarah Wright, et al.
The Journal of Bone and Joint Surgery. American Volume|February 22, 2013
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) projectBeatrice J Edwards, Andrew D Bunta, Joseph Lane, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
American Journal of Therapeutics|January 8, 2009
Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient settingAllison J Hahr, Mark E Molitch
Cardiology Clinics|July 13, 2010
Diabetes, cardiovascular risk and nephropathyAllison J Hahr, Mark E Molitch
Clinical Diabetes and Endocrinology|July 14, 2017
Management of diabetes mellitus in patients with chronic kidney diseaseAllison J Hahr, Mark E Molitch
Disease-A-Month : DM|March 2, 2010
Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient settingAllison J Hahr, Mark E Molitch
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 3, 2021
Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022Allison J Hahr, Mark E Molitch
BMC Research Notes|November 1, 2012
Primary hyperaldosteronism: challenges in subtype classificationBrian T Layden, Allison J Hahr, Dina M Elaraj
Disease-A-Month : DM|March 2, 2010
Topics in clinical pharmacology: cardiovascular and diabetes mellitusJohn Somberg, Antonio Cherubini, David T Lowenthal, et al.
Journal of Medical Internet Research|October 23, 2019
Electronic Health Record-Based Strategy to Promote Medication Adherence Among Patients With Diabetes: Longitudinal Observational StudyStacy Cooper Bailey, Amisha Wallia, Sarah Wright, et al.
The Journal of Bone and Joint Surgery. American Volume|February 22, 2013
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) projectBeatrice J Edwards, Andrew D Bunta, Joseph Lane, et al.
Pageof 1